Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade
Victoria Klepsch, Natascha Hermann‐Kleiter, Patricia Do-Dinh, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Dongrui Wang, Xianlin Wu, Yingli Sun
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 290
A proteogenomic portrait of lung squamous cell carcinoma
Shankha Satpathy, Karsten Krug, Pierre M. Jean Beltran, et al.
Cell (2021) Vol. 184, Iss. 16, pp. 4348-4371.e40
Open Access | Times Cited: 275
Targeted Intracellular Delivery of Antibodies: The State of the Art
Tatiana A. Slastnikova, A. V. Ulasov, Andrey A. Rosenkranz, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 179
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115306-115306
Open Access | Times Cited: 20
Deletion of Cbl-b inhibits CD8+ T-cell exhaustion and promotes CAR T-cell function
Jitendra Kumar, Ritesh Kumar, Amir Kumar Singh, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001688-e001688
Open Access | Times Cited: 85
Ontogeny of arterial macrophages defines their functions in homeostasis and inflammation
Tobias Weinberger, Dena Esfandyari, Denise Messerer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 71
Strategies targeting tumor immune and stromal microenvironment and their clinical relevance
Mengying Hu, Leaf Huang
Advanced Drug Delivery Reviews (2022) Vol. 183, pp. 114137-114137
Open Access | Times Cited: 42
Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer therapy
Fenggang Qi, Qunqun Bao, Ping Hu, et al.
Biomaterials (2024) Vol. 307, pp. 122514-122514
Closed Access | Times Cited: 12
Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD
Victoria Klepsch, Alexander R. Moschen, Herbert Tilg, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 58
PD-1 Imposes Qualitative Control of Cellular Transcriptomes in Response to T Cell Activation
Kenji Shimizu, Daisuke Sugiura, Il‐mi Okazaki, et al.
Molecular Cell (2020) Vol. 77, Iss. 5, pp. 937-950.e6
Open Access | Times Cited: 51
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence
Florian Huemer, Michael Leisch, Roland Geisberger, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2856-2856
Open Access | Times Cited: 43
Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC
Nathan Wamsley, Emily Wilkerson, Li Guan, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 11, pp. 100647-100647
Open Access | Times Cited: 14
MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma
Chang’e Jin, Xiao Liang, Zeqiang Zhou, et al.
Human Cell (2019) Vol. 32, Iss. 4, pp. 437-446
Closed Access | Times Cited: 37
NR2F6 regulates stem cell hematopoiesis and myelopoiesis in mice
Johannes Woelk, Hamsa Narasimhan, Christa Pfeifhofer-Obermair, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway
Han Li, Weijing Zhang, Chunhao Niu, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 7, pp. 1921-1934
Open Access | Times Cited: 33
Emerging roles of circular RNAs in liver cancer
Corentin Louis, Delphine Leclerc, Cédric Coulouarn
JHEP Reports (2021) Vol. 4, Iss. 2, pp. 100413-100413
Open Access | Times Cited: 26
eQTLs identify regulatory networks and drivers of variation in the individual response to sepsis
Katie L. Burnham, Nikhil Milind, Wanseon Lee, et al.
Cell Genomics (2024) Vol. 4, Iss. 7, pp. 100587-100587
Open Access | Times Cited: 3
Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy
David J. Zahavi, Louis M. Weiner
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 1, pp. 158-158
Open Access | Times Cited: 28
Orphan Nuclear Receptor NR2F6 Suppresses T Follicular Helper Cell Accumulation through Regulation of IL-21
William J. Olson, Bojana Jakic, Verena Labi, et al.
Cell Reports (2019) Vol. 28, Iss. 11, pp. 2878-2891.e5
Open Access | Times Cited: 28
A Novel Wick‐Like Paper‐Based Microfluidic Device for 3D Cell Culture and Anti‐Cancer Drugs Screening
Shu‐xia Fu, Peng Zuo, Bang‐Ce Ye
Biotechnology Journal (2020) Vol. 16, Iss. 2
Closed Access | Times Cited: 25
New Insights into the Diverse Functions of the NR2F Nuclear Orphan Receptor Family
Tajana Sajinovic, Gottfried Baier
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 8
Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology
Guocheng Rao, Peng Xi, Yan Tian, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8
Loss of the orphan nuclear receptor NR2F6 enhances CD8+ T-cell memory via IFN-γ
Bojana Jakic, William J. Olson, Kerstin Siegmund, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 18
Ultra-thin layered double hydroxide-mediated photothermal therapy combine with asynchronous blockade of PD-L1 and NR2F6 inhibit hepatocellular carcinoma
Yuan‐Fei Lu, Jia-Ping Zhou, Qiao-Mei Zhou, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Regulation of PD-L1 Expression by Nuclear Receptors
Yoshimitsu Kiriyama, Hiromi Nochi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9891-9891
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top